Intrinsic Value

CRISPR Therapeutics AG (CRSP)

$57.03

+1.37 (+2.46%)

Enterprise Value -100,922,005,289,850,535,936
Net Debt -150.84
Equity Value -100,922,005,289,850,535,936
Shares Outstanding 79.22
Equity Value Per Share -1,273,931,084,750,589,696.00



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt